Evidence map›Paper›PMID 31672938›Full record

ArticleJCI insight2019

NK cell defects in X-linked pigmentary reticulate disorder.

Petro Starokadomskyy, Katelynn M Wilton, Konrad Krzewski, Adam Lopez, Luis Sifuentes-Dominguez, Brittany Overlee, Qing Chen, Ann Ray, Aleksandra Gil-Krzewska, Mary Peterson and 7 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Human natural killer cells: Form, function, and development.The Journal of allergy and clinical immunology · 2023
    Review
  7. Article
  8. Article
  9. X-linked reticulate pigmentary disorder in a 4-year-old boy.Postepy dermatologii i alergologii · 2022
    Article
  10. Editorial: Pattern-recognition receptors: Genetics, immunity, pathology.Frontiers in cellular and infection microbiology · 2022
    Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 3 countries.

Petro StarokadomskyyDepartment of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Katelynn M WiltonDepartment of Immunology and Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Konrad KrzewskiReceptor Cell Biology Section, Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, NIH, Rockville, Maryland, USA.
Adam LopezDepartment of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Luis Sifuentes-DominguezDepartment of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Brittany OverleeDepartment of Immunology and Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Qing ChenDepartment of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Ann RayDepartment of Microbiology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Aleksandra Gil-KrzewskaReceptor Cell Biology Section, Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, NIH, Rockville, Maryland, USA.
Mary PetersonMolecular and Cellular Immunology Section, Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, NIH, Rockville, Maryland, USA.
Lisa N KinchHoward Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Luis RohenaDivision of Genetics, Department of Pediatrics, San Antonio Military Medical Center, San Antonio, Texas, USA.
Eyal GrunebaumDivision of Immunology and Allergy and Department of Pediatrics, Developmental and Stem Cell Biology Program, Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada.
Andrew R ZinnDepartment of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Nick V GrishinHoward Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Daniel D BilladeauDepartment of Immunology and Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Ezra BursteinDepartment of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
The University of Texas Southwestern Medical Center · USMayo Clinic · USNational Institute of Allergy and Infectious Diseases · USHoward Hughes Medical Institute · USBrooke Army Medical Center · USHospital for Sick Children · CAMcDermott International (United States) · USTongji University · CN

Funding

Medical Scientist Traning Program at Mayo ClinicT32GM065841 · NIGMS · MAYO CLINIC ROCHESTER · PI KAUFMANN, SCOTT H, SCHIMMENTI, LISA A · 2003 to 2022
$5.8M
MECHANISMS OF NATURAL KILLER CELL ACTIVATIONR01CA047752 · NCI · MAYO CLINIC ROCHESTER · PI BILLADEAU, DANIEL D · 1990 to 2012
$3.8M
Role of the CCC complex in immune functionR01DK073639 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI BURSTEIN, EZRA · 2007 to 2020
$3.7M
Mechanisms Regulating Human NK Cell CytotoxicityR01AI120949 · NIAID · MAYO CLINIC ROCHESTER · PI BILLADEAU, DANIEL D · 2016 to 2020
$2.0M
NF-kB Signaling Insights from a Rare X-linked Immunodeficiency SyndromeR56AI113274 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI BURSTEIN, EZRA, ZINN, ANDREW R. · 2014 to 2014
$398k
Howard Hughes Medical InstituteNCI NIH HHS R01 CA047752NIAID NIH HHS R01 AI120949NIAID NIH HHS R56 AI113274NIDDK NIH HHS R01 DK073639NIGMS NIH HHS T32 GM065841
6 · The paper itself

Abstract

X-linked reticulate pigmentary disorder (XLPDR, Mendelian Inheritance in Man #301220) is a rare syndrome characterized by recurrent infections and sterile multiorgan inflammation. The syndrome is caused by an intronic mutation in POLA1, the gene encoding the catalytic subunit of DNA polymerase-α (Pol-α), which is responsible for Okazaki fragment synthesis during DNA replication. Reduced POLA1 expression in this condition triggers spontaneous type I interferon expression, which can be linked to the autoinflammatory manifestations of the disease. However, the history of recurrent infections in this syndrome is as yet unexplained. Here we report that patients with XLPDR have reduced NK cell cytotoxic activity and decreased numbers of NK cells, particularly differentiated, stage V, cells (CD3-CD56dim). This phenotype is reminiscent of hypomorphic mutations in MCM4, which encodes a component of the minichromosome maintenance (MCM) helicase complex that is functionally linked to Pol-α during the DNA replication process. We find that POLA1 deficiency leads to MCM4 depletion and that both can impair NK cell natural cytotoxicity and show that this is due to a defect in lytic granule polarization. Altogether, our study provides mechanistic connections between Pol-α and the MCM complex and demonstrates their relevance in NK cell function.

Indexed as

Amyloidosis, FamilialCytotoxicity, ImmunologicDNA RepairGenetic Diseases, X-LinkedHumansK562 CellsKiller Cells, NaturalMinichromosome Maintenance Complex Component 4Pigmentation DisordersRecombination, GeneticSkin Diseases, GeneticMCM4 protein, humanMinichromosome Maintenance Complex Component 4Infectious diseaseInflammationInnate immunityMonogenic diseasesNK cells

Identifiers

PMID31672938
PMCPMC6948767
OpenAlexW2986017518

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.